Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk scorePhilip L. De Jager, Elizabeth W. Karlson, Lori B. Chibnik et al.|The Lancet Neurology|2009Cited by 268
Evaluation of a Series of Naphthamides as Potent, Orally Active Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase InhibitorsMatthew M. Weiss, Roger Zanon, Loren Berry et al.|Journal of Medicinal Chemistry|2008Cited by 34